Elsevier

Brain Stimulation

Volume 6, Issue 4, July 2013, Pages 708-709
Brain Stimulation

Letter to the Editor
Monotherapy with tDCS for Schizophrenia: A Case Report

https://doi.org/10.1016/j.brs.2013.01.007Get rights and content

References (9)

There are more references available in the full text version of this article.

Cited by (35)

  • Brain connectivity and auditory hallucinations: In search of novel noninvasive brain stimulation therapeutic approaches for schizophrenia

    2016, Revue Neurologique
    Citation Excerpt :

    The number of sessions varied from five [118,123] to 20 [115]. AVH were assessed with the AHRS [110–114,117,119,120,123], the PANSS [115,123,125], the PSYRATS [114,118] and the HCS [109]. All of the case studies cited above, excepting one [113], reported improvements of AVH.

  • A systematic review of the clinical efficacy of transcranial direct current stimulation (tDCS) in psychiatric disorders

    2016, Journal of Psychiatric Research
    Citation Excerpt :

    A number of case reports/series describing patients with refractory schizophrenia have also offered support (Brunelin et al., 2012b; Jacks et al., 2014; Narayanaswamy et al., 2014; Nawani et al., 2014a, 2014b; Rakesh et al., 2013; Shenoy et al., 2015; Shivakumar et al., 2014). For instance, Shenoy et al. (2015) recorded near-total improvement of the exacerbation of AVHs during pregnancy, Narayanaswamy et al. (2014) noted a delayed but persistent improvement in negative symptoms, and Rakesh et al. (2013) observed complete cessation of AVHs immediately after the first two tDCS sessions and at post-intervention re-assessment. Shivakumar et al. (2014) also witnessed a tDCS-induced termination of AVHs, and subsequently found that application of intermittent booster tDCS (6 sessions) resulted in sustained improvements for a period of one year.

  • Impact of antipsychotic medication on transcranial direct current stimulation (tDCS) effects in schizophrenia patients

    2015, Psychiatry Research
    Citation Excerpt :

    tDCS has been demonstrated to be effective in reducing auditory hallucinations by presumably decreasing hyperactivity of the temporo-parietal junction (TPJ) in the first monocentric proof-of-principle trial (Brunelin et al., 2012). Indeed, pilot studies have demonstrated a significant clinical improvement with tDCS, with respect to auditory hallucinations (Brunelin et al., 2012; Mondino et al., 2015b; Rakesh et al., 2013; Shivakumar et al., 2013), negative symptoms (Brunelin et al., 2012; Kurimori et al., 2015; Mondino et al., 2015b) and insight into the origin and reality of psychotic experiences (Bose et al., 2014). Several factors are known or presumed to affect the neuroplasticity-inducing potential of tDCS, such as subjects’ age and sex, genetic profile, history of past response to tDCS or repetitive transcranial magnetic stimulation (rTMS) and medication (Ridding and Ziemann, 2010).

  • Clinical use of Transcranial Direct Current Stimulation in Psychiatry

    2014, The Stimulated Brain: Cognitive Enhancement Using Non-Invasive Brain Stimulation
View all citing articles on Scopus

Financial support: GR, AS, HN and JCN are supported by the Department of Science & Technology, Government of India. VS is supported by the Indian Council of Medical Research. ACA & GV are supported by the Wellcome Trust/DBT India Alliance.

Conflict of interest: There are no potential conflicts of interest to report for any of the authors.

View full text